Key result
Cyclosporin A substantially attenuated compensatory myocardial hypertrophy in rats with congestive heart failure, but led to increased left ventricular dilatation and reduced cardiac function.
Why the study?
Does cyclosporin A inhibit myocardial hypertrophy and affect cardiac remodeling in rats with postinfarction congestive heart failure?
RCT
randomized
Does cyclosporin A inhibit myocardial hypertrophy and affect cardiac remodeling in rats with postinfarction congestive heart failure?
Inhibition of calcineurin by cyclosporin A attenuates compensatory myocardial hypertrophy but aggravates cardiac dysfunction and remodeling after myocardial infarction in rats.
Answers are grounded in this paper and cite their sources.
Calcineurin inhibition may blunt compensatory hypertrophy but worsen remodeling in experimental HF; leaves open human relevance.
Calcineurin has recently been implicated as a mediator in the signaling pathways that transform intracellular calcium signals to the phenotype of myocardial hypertrophy. The present study was conducted to examine the effects of cyclosporin A (CsA), an inhibitor of calcineurin, on myocardial hypertrophy and remodeling during congestive heart failure (CHF) in rats. After ligation of the left coronary artery, rats were randomized to treatment with CsA or vehicle for 14 days. Compared with vehicle, CsA substantially attenuated myocardial hypertrophy in the CHF rats as assessed by alterations in ventricular weight-to-tibial length ratios (P < 0.05). Myocardial gene expression of skeletal alpha-actin was also reduced in the failing left ventricle (LV) after treatment with CsA (P < 0. 05), although the mRNA levels were still substantially elevated relative to those of sham rats. CsA-induced inhibition of compensatory myocardial hypertrophy in the CHF rats led to increased dilatation of the LV cavity and reduced fractional shortening and peak positive and negative first derivatives of LV pressure (P < 0. 05). Plasma renin and endothelin-1 levels were increased in the CHF-CsA rats, providing humoral cues of aggravated cardiac function. Thus this study supports a crucial role of calcineurin-dependent pathways in the mechanisms of compensatory myocardial hypertrophy during CHF. In addition, our data indicate that inhibition of compensatory myocardial hypertrophy exerts detrimental effects on cardiac remodeling and function after myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Øie et al. (2000) conducted an RCT in Congestive heart failure (CHF) post-myocardial infarction. Cyclosporin A (CsA) vs. Vehicle was evaluated on Myocardial hypertrophy assessed by ventricular weight-to-tibial length ratios (p=<0.05). Cyclosporin A substantially attenuated compensatory myocardial hypertrophy in rats with congestive heart failure, but led to increased left ventricular dilatation and reduced cardiac function.
Synapse has enriched 10 related papers. Consider them for comparative context: